1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Takeda, A. Wakamatsu, K. Tachi, T. Matsuzaki, K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.0 90.0 90.0 1.0 1.0 1.0 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biopolymers BIPMAA 0161 0006-3525 58 437 446 10.1002/1097-0282(20010405)58:4<437::AID-BIP1019>3.3.CO;2-9 11180056 Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue. 2001 10.2210/pdb1dum/pdb pdb_00001dum 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2526.973 MAGAININ 2 F5Y, F16W 2 syn polymer no no GIGKYLHSAKKFGKAWVGEIMNS GIGKYLHSAKKFGKAWVGEIMNS A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-06-27 1 1 2008-04-27 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details RCSB Y RCSB 2000-01-18 REL REL The peptide was prepared by solid-phase synthesis. The sequence of this peptide naturally occurs in Xenopus laevis (African clawed frog) sample This structure was determined using standard 2D homonuclear techniques. structures with the lowest energy 100 10 2D NOESY 50mM 5.2 ambient 318 K The structures are based on 466 NOE-derived distance constraints (per protomer), 32 of which are treated as ambiguous. simulated annealing 1 lowest energy 5mM [F5Y, F16W] magainin 2, 0.5mM DLPC-d64 90% H2O/10% D2O Bruker collection UXNMR 1.3 Brunger refinement X-PLOR 3.1 400 Bruker ARX GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A GLY 3 n 3 GLY 3 A LYS 4 n 4 LYS 4 A TYR 5 n 5 TYR 5 A LEU 6 n 6 LEU 6 A HIS 7 n 7 HIS 7 A SER 8 n 8 SER 8 A ALA 9 n 9 ALA 9 A LYS 10 n 10 LYS 10 A LYS 11 n 11 LYS 11 A PHE 12 n 12 PHE 12 A GLY 13 n 13 GLY 13 A LYS 14 n 14 LYS 14 A ALA 15 n 15 ALA 15 A TRP 16 n 16 TRP 16 A VAL 17 n 17 VAL 17 A GLY 18 n 18 GLY 18 A GLU 19 n 19 GLU 19 A ILE 20 n 20 ILE 20 A MET 21 n 21 MET 21 A ASN 22 n 22 ASN 22 A SER 23 n 23 SER 23 A GLY 1 n 1 GLY 1 B ILE 2 n 2 ILE 2 B GLY 3 n 3 GLY 3 B LYS 4 n 4 LYS 4 B TYR 5 n 5 TYR 5 B LEU 6 n 6 LEU 6 B HIS 7 n 7 HIS 7 B SER 8 n 8 SER 8 B ALA 9 n 9 ALA 9 B LYS 10 n 10 LYS 10 B LYS 11 n 11 LYS 11 B PHE 12 n 12 PHE 12 B GLY 13 n 13 GLY 13 B LYS 14 n 14 LYS 14 B ALA 15 n 15 ALA 15 B TRP 16 n 16 TRP 16 B VAL 17 n 17 VAL 17 B GLY 18 n 18 GLY 18 B GLU 19 n 19 GLU 19 B ILE 20 n 20 ILE 20 B MET 21 n 21 MET 21 B ASN 22 n 22 ASN 22 B SER 23 n 23 SER 23 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B O H ALA GLY 9 13 1.43 1 A A O H ALA GLY 9 13 1.47 1 B B O H PHE TRP 12 16 1.57 1 A A O H PHE TRP 12 16 1.58 1 B B O H LYS ALA 4 9 1.59 2 A A O H ALA GLY 9 13 1.46 2 A A O H PHE TRP 12 16 1.52 2 B B O H ALA GLY 9 13 1.57 3 B B O H ALA GLY 9 13 1.43 3 A A O H ALA GLY 9 13 1.43 4 B B O H ALA GLY 9 13 1.46 4 A A O H ALA GLY 9 13 1.50 4 A A O H PHE TRP 12 16 1.59 5 A A O H ALA GLY 9 13 1.46 5 B B O H ALA GLY 9 13 1.56 5 B B O H PHE TRP 12 16 1.59 6 A A O H ALA GLY 9 13 1.47 6 B B O H ALA GLY 9 13 1.49 6 B B O H PHE TRP 12 16 1.57 6 A A O H PHE TRP 12 16 1.58 7 A A O H ALA GLY 9 13 1.45 7 A A O H PHE TRP 12 16 1.48 7 B B O H PHE TRP 12 16 1.58 7 B B O H ALA GLY 9 13 1.58 8 A A O H ALA GLY 9 13 1.42 8 B B O H ALA GLY 9 13 1.45 8 B B O H LYS ALA 4 9 1.46 8 B B O H PHE TRP 12 16 1.53 9 A A O H ALA GLY 9 13 1.41 9 A A O H LYS ALA 4 9 1.54 9 A A O H PHE TRP 12 16 1.57 9 B B O H ALA GLY 9 13 1.58 10 B B O H ALA GLY 9 13 1.43 10 A A O H ALA GLY 9 13 1.44 10 A A O H LYS SER 4 8 1.54 1 A ILE 2 64.19 131.40 1 A HIS 7 -149.39 13.48 1 A SER 8 -165.39 -37.49 1 B ILE 2 62.44 91.72 1 B LYS 4 -146.36 -41.37 2 A LYS 4 -158.87 -41.34 2 A HIS 7 -131.14 -31.64 2 A ALA 9 -51.19 -75.72 2 A LYS 10 -29.16 -42.66 2 B LYS 4 -148.61 -46.03 2 B HIS 7 -141.29 12.91 2 B SER 8 -164.89 -35.72 2 B GLU 19 -91.89 -68.82 3 A LYS 4 175.84 -48.45 3 A SER 8 -157.98 -37.66 3 A GLU 19 -91.32 -64.11 3 B LYS 4 175.31 -46.22 3 B HIS 7 -142.36 -32.97 3 B LYS 10 -30.85 -39.20 4 A LYS 4 -136.22 -41.56 4 A HIS 7 -151.61 -28.42 4 A ALA 9 -92.24 -63.80 4 A GLU 19 -86.65 -72.44 4 B LYS 4 -137.10 -45.94 4 B SER 8 -168.94 -35.26 5 A LYS 4 -147.26 -41.78 5 A HIS 7 -140.31 12.51 5 A SER 8 -165.85 -36.55 5 A ALA 9 -60.40 -70.89 5 A GLU 19 -91.32 -65.75 5 B HIS 7 -152.81 -30.41 5 B LYS 10 -39.64 -34.78 6 A LYS 4 -144.05 -41.89 6 A SER 8 -163.23 -36.32 6 B ILE 2 51.66 78.65 6 B LYS 4 -135.67 -44.68 6 B SER 8 -158.24 -37.38 6 B GLU 19 -86.82 -72.50 7 A LYS 4 -136.77 -39.69 7 A SER 8 -169.49 -37.93 7 A GLU 19 -87.22 -71.32 7 B LYS 4 -136.91 -39.35 7 B SER 8 -171.16 -34.22 7 B GLU 19 -87.69 -71.90 8 A ILE 2 59.40 75.38 8 A LYS 4 -137.70 -40.64 8 A SER 8 -165.26 -36.26 8 A LYS 10 -28.67 -48.05 8 A GLU 19 -92.92 -61.57 8 B SER 8 -141.90 -38.19 8 B GLU 19 -90.63 -67.85 9 A ILE 2 -153.66 70.51 9 A LYS 4 -133.39 -35.01 9 A HIS 7 -147.84 14.78 9 A SER 8 -159.95 -39.42 9 A LYS 10 -25.00 -54.15 9 A GLU 19 -88.58 -71.61 9 B ILE 2 62.67 63.39 9 B LYS 4 -142.97 -47.54 9 B SER 8 -167.27 -37.67 9 B GLU 19 -105.94 -68.52 10 A ILE 2 -163.44 63.85 10 A LYS 4 -134.12 -43.81 10 A HIS 7 -136.84 -30.87 10 A GLU 19 -90.01 -63.93 10 B HIS 7 -152.66 16.95 10 B SER 8 -165.60 -38.99 10 B GLU 19 -93.90 -65.43 NMR STRUCTURE OF [F5Y, F16W] MAGAININ 2 BOUND TO PHOSPHOLIPID VESICLES 1 N N 1 N N A SER 8 A SER 8 HELX_P A MET 21 A MET 21 1 1 14 B SER 8 B SER 8 HELX_P B MET 21 B MET 21 1 2 14 ANTIMICROBIAL PROTEIN antibiotic, magainin, dimer, amphipathic helix, membrane, vesicle, bilayer, ANTIMICROBIAL PROTEIN MAGA_XENLA UNP 1 129 P11006 MFKGLFICSLIAVICANALPQPEASADEDMDEREVRGIGKFLHSAGKFGKAFVGEIMKSKRDAEAVGPEAFADEDLDERE VRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGP EAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFADEDFDEREVRGIGKFLHSAKKFGKAFVGEI MNSKRDAEAVGPEAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVDDRRWVE 129 151 1DUM 1 23 P11006 A 1 1 23 129 151 1DUM 1 23 P11006 B 1 1 23 1 PHE engineered mutation TYR 5 1DUM A P11006 UNP 133 5 1 PHE engineered mutation TRP 16 1DUM A P11006 UNP 144 16 2 PHE engineered mutation TYR 5 1DUM B P11006 UNP 133 5 2 PHE engineered mutation TRP 16 1DUM B P11006 UNP 144 16 1 P 1